Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1992-09-25
1994-03-01
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514362, 514365, 514374, 514414, 548134, 548143, 548181, 548236, 548467, C07D41712, A61K 31425, A61K 3141
Patent
active
052907988
ABSTRACT:
Compounds having the formula I: ##STR1## are inhibitors of leukotriene biosynthesis. These compounds are useful as anti-asthmatic, anti-allergic, anti-inflammatory, and cytoprotective agents. They are also useful in treating diarrhea, hypertension, angina, platelet aggregation, cerebral spasm, premature labor, spontaneous abortion, dysmenorrhea, and migraine.
REFERENCES:
patent: 4629733 (1986-12-01), Muiller et al.
patent: 5034403 (1991-07-01), Effland et al.
patent: 5095031 (1992-03-01), Brooks et al.
Sheinkman et al. Chem. Ab., vol. 67, 54017 (1967).
Biniecki et al. Chem. Ab., vol. 98, 197936 (1983).
Pakula et al., Chem. Ab., vol. 105, 190835 (1986).
Gillard John W.
Hutchinson John H.
Therien Michel
Daniel Mark R.
DiPrima Joseph F.
Gerstl Robert
Merck Frosst Canada Inc.
LandOfFree
(hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynt does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynt, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynt will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-577402